{
  "DOI": "10.1007/s10689-015-9851-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9851-7",
  "alternative-id": [
    "9851"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Poumpouridou",
      "given": "Nikoleta",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Goutas",
      "given": "Nikolaos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tsionou",
      "given": "Christina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dimas",
      "given": "Kleanthi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lianidou",
      "given": "Evi",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5876-2599",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kroupis",
      "given": "Christos",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        11,
        14
      ]
    ],
    "date-time": "2015-11-14T07:05:38Z",
    "timestamp": 1447484738000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:16Z",
    "timestamp": 1559252776000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        5
      ]
    ],
    "date-time": "2022-04-05T02:38:17Z",
    "timestamp": 1649126297782
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2015,
        11,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2016,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            11,
            14
          ]
        ],
        "date-time": "2015-11-14T00:00:00Z",
        "timestamp": 1447459200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9851-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9851-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9851-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "183-191",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        11,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        11,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/ijc.29210",
      "author": "J Ferlay",
      "doi-asserted-by": "crossref",
      "first-page": "359",
      "journal-title": "Int J Cancer",
      "key": "9851_CR1",
      "unstructured": "Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:359–386",
      "volume": "136",
      "year": "2015"
    },
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "crossref",
      "first-page": "812",
      "journal-title": "J Natl Cancer Inst",
      "key": "9851_CR2",
      "unstructured": "Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812–822",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "497",
      "journal-title": "N Engl J Med",
      "key": "9851_CR3",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De LK, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497–506",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1515/cclm-2011-0840",
      "author": "N Poumpouridou",
      "doi-asserted-by": "crossref",
      "first-page": "423",
      "journal-title": "Clin Chem Lab Med",
      "key": "9851_CR4",
      "unstructured": "Poumpouridou N, Kroupis C (2012) Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges. Clin Chem Lab Med 50:423–434",
      "volume": "50",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.gde.2010.02.009",
      "author": "A Hollestelle",
      "doi-asserted-by": "crossref",
      "first-page": "268",
      "journal-title": "Curr Opin Genet Dev",
      "key": "9851_CR5",
      "unstructured": "Hollestelle A, Wasielewski M, Martens JW, Schutte M (2010) Discovering moderate-risk breast cancer susceptibility genes. Curr Opin Genet Dev 20:268–276",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10911-011-9213-5",
      "author": "AY Shuen",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "journal-title": "J Mammary Gland Biol Neoplasia",
      "key": "9851_CR6",
      "unstructured": "Shuen AY, Foulkes WD (2011) Inherited mutations in breast cancer genes-risk and response. J Mammary Gland Biol Neoplasia 16:3–15",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.569",
      "author": "A Meindl",
      "doi-asserted-by": "crossref",
      "first-page": "410",
      "journal-title": "Nat Genet",
      "key": "9851_CR7",
      "unstructured": "Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42:410–414",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.molcel.2006.05.022",
      "author": "B Xia",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "journal-title": "Mol Cell",
      "key": "9851_CR8",
      "unstructured": "Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22:719–729",
      "volume": "22",
      "year": "2006"
    },
    {
      "DOI": "10.1126/science.1174839",
      "author": "DM Livingston",
      "doi-asserted-by": "crossref",
      "first-page": "602",
      "journal-title": "Science",
      "key": "9851_CR9",
      "unstructured": "Livingston DM (2009) Cancer. Complicated supercomplexes. Science 324:602–603",
      "volume": "324",
      "year": "2009"
    },
    {
      "DOI": "10.1038/embor.2009.126",
      "author": "AW Oliver",
      "doi-asserted-by": "crossref",
      "first-page": "990",
      "journal-title": "EMBO Rep",
      "key": "9851_CR10",
      "unstructured": "Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH (2009) Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep 10:990–996",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1093/nar/gks807",
      "author": "R Buisson",
      "doi-asserted-by": "crossref",
      "first-page": "10312",
      "journal-title": "Nucleic Acids Res",
      "key": "9851_CR11",
      "unstructured": "Buisson R, Masson JY (2012) PALB2 self-interaction controls homologous recombination. Nucleic Acids Res 40:10312–10323",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.0811159106",
      "author": "SM Sy",
      "doi-asserted-by": "crossref",
      "first-page": "7155",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9851_CR12",
      "unstructured": "Sy SM, Huen MS, Chen J (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci USA 106:7155–7160",
      "volume": "106",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng1959",
      "author": "N Rahman",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "journal-title": "Nat Genet",
      "key": "9851_CR13",
      "unstructured": "Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165–167",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.21478",
      "author": "H Hellebrand",
      "doi-asserted-by": "crossref",
      "first-page": "E2176",
      "journal-title": "Hum Mutat",
      "key": "9851_CR14",
      "unstructured": "Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, Deissler H, Ditsch N, Gress V, Kiechle M, Bartram CR, Schmutzler RK, Niederacher D, Arnold N, Meindl A (2011) Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat 32:E2176–E2188",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1186/bcr2796",
      "author": "MC Southey",
      "doi-asserted-by": "crossref",
      "first-page": "R109",
      "journal-title": "Breast Cancer Res",
      "key": "9851_CR15",
      "unstructured": "Southey MC, Teo ZL, Dowty JG, Odefrey FA, Park DJ, Tischkowitz M, Sabbaghian N, Apicella C, Byrnes GB, Winship I, Baglietto L, Giles GG, Goldgar DE, Foulkes WD, Hopper JL (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res 12:R109",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cncr.28504",
      "author": "PH Fernandes",
      "doi-asserted-by": "crossref",
      "first-page": "963",
      "journal-title": "Cancer",
      "key": "9851_CR16",
      "unstructured": "Fernandes PH, Saam J, Peterson J, Hughes E, Kaldate R, Cummings S, Theisen A, Chen S, Trost J, Roa BB (2014) Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer. Cancer 120:963–967",
      "volume": "120",
      "year": "2014"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-3958",
      "author": "S Casadei",
      "doi-asserted-by": "crossref",
      "first-page": "2222",
      "journal-title": "Cancer Res",
      "key": "9851_CR17",
      "unstructured": "Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, Stamatoyannopoulos JA, King MC (2011) Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 71:2222–2229",
      "volume": "71",
      "year": "2011"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-13-0745-T",
      "author": "M Janatova",
      "doi-asserted-by": "crossref",
      "first-page": "2323",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9851_CR18",
      "unstructured": "Janatova M, Kleibl Z, Stribrna J, Panczak A, Vesela K, Zimovjanova M, Kleiblova P, Dundr P, Soukupova J, Pohlreich P (2013) The PALB2 gene is a strong candidate for clinical testing in BRCA1 and BRCA2 negative hereditary breast cancer. Cancer Epidemiol Biomarkers Prev 22:2323–2332",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng1947",
      "author": "S Reid",
      "doi-asserted-by": "crossref",
      "first-page": "162",
      "journal-title": "Nat Genet",
      "key": "9851_CR19",
      "unstructured": "Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162–164",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10549-010-0797-z",
      "author": "V Silvestri",
      "doi-asserted-by": "crossref",
      "first-page": "299",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR20",
      "unstructured": "Silvestri V, Rizzolo P, Zanna I, Falchetti M, Masala G, Bianchi S, Papi L, Giannini G, Palli D, Ottini L (2010) PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat 122:299–301",
      "volume": "122",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-010-1195-2",
      "author": "YC Ding",
      "doi-asserted-by": "crossref",
      "first-page": "771",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR21",
      "unstructured": "Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL (2011) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat 126:771–778",
      "volume": "126",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10689-011-9426-1",
      "author": "EW Hofstatter",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "Fam Cancer",
      "key": "9851_CR22",
      "unstructured": "Hofstatter EW, Domchek SM, Miron A, Garber J, Wang M, Componeschi K, Boghossian L, Miron PL, Nathanson KL, Tung N (2011) PALB2 mutations in familial breast and pancreatic cancer. Fam Cancer 10:225–231",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1399-0004.2010.01425.x",
      "author": "EP Slater",
      "doi-asserted-by": "crossref",
      "first-page": "490",
      "journal-title": "Clin Genet",
      "key": "9851_CR23",
      "unstructured": "Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoptolemos JP, Greenhalf W, Bartsch DK (2010) PALB2 mutations in European familial pancreatic cancer families. Clin Genet 78:490–494",
      "volume": "78",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.0701724104",
      "author": "M Tischkowitz",
      "doi-asserted-by": "crossref",
      "first-page": "6788",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9851_CR24",
      "unstructured": "Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104:6788–6793",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.22022",
      "author": "M Tischkowitz",
      "doi-asserted-by": "crossref",
      "first-page": "674",
      "journal-title": "Hum Mutat",
      "key": "9851_CR25",
      "unstructured": "Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallee MP, Tavtigian SV, Concannon P, Foulkes WD, Bernstein L, Bernstein JL, Begg CB (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 33:674–680",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng1942",
      "author": "B Xia",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "journal-title": "Nat Genet",
      "key": "9851_CR26",
      "unstructured": "Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159–161",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10549-011-1842-2",
      "author": "A Blanco",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR27",
      "unstructured": "Blanco A, de la Hoya M, Balmana J, Ramon YC, Teule A, Miramar MD, Esteban E, Infante M, Benitez J, Torres A, Tejada MI, Brunet J, Grana B, Balbin M, Perez-Segura P, Osorio A, Velasco EA, Chirivella I, Calvo MT, Feliubadalo L, Lasa A, Diez O, Carracedo A, Caldes T, Vega A (2012) Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res Treat 132:307–315",
      "volume": "132",
      "year": "2012"
    },
    {
      "DOI": "10.1186/bcr1828",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "R83",
      "journal-title": "Breast Cancer Res",
      "key": "9851_CR28",
      "unstructured": "Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9:R83",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1471-2350-14-5",
      "author": "M Tischkowitz",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "journal-title": "BMC Med Genet",
      "key": "9851_CR29",
      "unstructured": "Tischkowitz M, Sabbaghian N, Hamel N, Pouchet C, Foulkes WD, Mes-Masson AM, Provencher DM, Tonin PN (2013) Contribution of the PALB2 c.2323C \u003e T [p. Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. BMC Med Genet 14:5",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1471-2350-11-20",
      "author": "A Dansonka-Mieszkowska",
      "doi-asserted-by": "crossref",
      "first-page": "20",
      "journal-title": "BMC Med Genet",
      "key": "9851_CR30",
      "unstructured": "Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-013-9684-1",
      "author": "M Noskowicz",
      "doi-asserted-by": "crossref",
      "first-page": "137",
      "journal-title": "Fam Cancer",
      "key": "9851_CR31",
      "unstructured": "Noskowicz M, Bogdanova N, Bermisheva M, Takhirova Z, Antonenkova N, Khusnutdinova E, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Dork T (2014) Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe. Fam Cancer 13:137–142",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature05609",
      "author": "H Erkko",
      "doi-asserted-by": "crossref",
      "first-page": "316",
      "journal-title": "Nature",
      "key": "9851_CR32",
      "unstructured": "Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319",
      "volume": "446",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1897-4287-12-19",
      "author": "T Hartley",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "9851_CR33",
      "unstructured": "Hartley T, Cavallone L, Sabbaghian N, Silva-Smith R, Hamel N, Aleynikova O, Smith E, Hastings V, Pinto P, Tischkowitz M, Tomiak E, Foulkes WD (2014) Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario Canada. Hered Cancer Clin Pract 12:19",
      "volume": "12",
      "year": "2014"
    },
    {
      "DOI": "10.2147/TACG.S34116",
      "author": "MC Southey",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "journal-title": "Appl Clin Genet",
      "key": "9851_CR34",
      "unstructured": "Southey MC, Teo ZL, Winship I (2013) PALB2 and breast cancer: ready for clinical translation! Appl Clin Genet 6:43–52",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1999)14:2\u003c95::AID-HUMU1\u003e3.0.CO;2-G",
      "author": "JT Dunnen Den",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "journal-title": "Hum Mutat",
      "key": "9851_CR35",
      "unstructured": "Den Dunnen JT, van Ommen GJ (1999) The protein truncation test: a review. Hum Mutat 14:95–102",
      "volume": "14",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0304-3835(01)00845-X",
      "author": "A Ladopoulou",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "Cancer Lett",
      "key": "9851_CR36",
      "unstructured": "Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, Armaou S, Tsiagas I, Lianidou ES, Efstathiou E, Tsionou C, Panopoulos C, Mihalatos M, Nasioulas G, Skarlos D, Haites N, Fountzilas G, Pandis N, Yannoukakos D (2002) Germ line BRCA1 \u0026 BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett 185:61–70",
      "volume": "185",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10549-010-1290-4",
      "author": "N Bogdanova",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR37",
      "unstructured": "Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M, Christiansen H, Rave-Frank M, Dork T, Imyanitov EN (2011) PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat 126:545–550",
      "volume": "126",
      "year": "2011"
    },
    {
      "DOI": "10.1038/modpathol.3800453",
      "author": "E Honrado",
      "doi-asserted-by": "crossref",
      "first-page": "1305",
      "journal-title": "Mod Pathol",
      "key": "9851_CR38",
      "unstructured": "Honrado E, Benitez J, Palacios J (2005) The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol 18:1305–1320",
      "volume": "18",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s13402-011-0010-3",
      "author": "P Groep van der",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "journal-title": "Cell Oncol",
      "key": "9851_CR39",
      "unstructured": "van der Groep P, van der Wall E, van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol 34:71–88",
      "volume": "34",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1399-0004.2003.00231.x",
      "author": "C Kroupis",
      "doi-asserted-by": "crossref",
      "first-page": "343",
      "journal-title": "Clin Genet",
      "key": "9851_CR40",
      "unstructured": "Kroupis C, Lianidou E, Goutas N, Vasilaros S, Yannoukakos D, Petersen MB (2004) Genetic counseling of medullary breast cancer patients. Clin Genet 65:343–344",
      "volume": "65",
      "year": "2004"
    },
    {
      "DOI": "10.1002/1097-0142(197710)40:4\u003c1365::AID-CNCR2820400402\u003e3.0.CO;2-N",
      "author": "RL Ridolfi",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "journal-title": "Cancer",
      "key": "9851_CR41",
      "unstructured": "Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 40:1365–1385",
      "volume": "40",
      "year": "1977"
    },
    {
      "DOI": "10.1007/s10549-011-1443-0",
      "author": "MW Wong",
      "doi-asserted-by": "crossref",
      "first-page": "853",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR42",
      "unstructured": "Wong MW, Nordfors C, Mossman D, Pecenpetelovska G, Avery-Kiejda KA, Talseth-Palmer B, Bowden NA, Scott RJ (2011) BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat 127:853–859",
      "volume": "127",
      "year": "2011"
    },
    {
      "DOI": "10.1002/cncr.26388",
      "author": "Y Zheng",
      "doi-asserted-by": "crossref",
      "first-page": "1362",
      "journal-title": "Cancer",
      "key": "9851_CR43",
      "unstructured": "Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI (2012) Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer 118:1362–1370",
      "volume": "118",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nbt857",
      "author": "G Traverso",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "journal-title": "Nat Biotechnol",
      "key": "9851_CR44",
      "unstructured": "Traverso G, Diehl F, Hurst R, Shuber A, Whitney D, Johnson C, Levin B, Kinzler KW, Vogelstein B (2003) Multicolor in vitro translation. Nat Biotechnol 21:1093–1097",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1002/humu.10024",
      "author": "S Kahmann",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "journal-title": "Hum Mutat",
      "key": "9851_CR45",
      "unstructured": "Kahmann S, Herter P, Kuhnen C, Muller KM, Muhr G, Martin D, Soddemann M, Muller O (2002) A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Hum Mutat 19:165–172",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2011.089474",
      "author": "J Necker",
      "doi-asserted-by": "crossref",
      "first-page": "526",
      "journal-title": "J Med Genet",
      "key": "9851_CR46",
      "unstructured": "Necker J, Kovac M, Attenhofer M, Reichlin B, Heinimann K (2011) Detection of APC germ line mosaicism in patients with de novo familial adenomatous polyposis: a plea for the protein truncation test. J Med Genet 48:526–529",
      "volume": "48",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1755-8794-6-48",
      "author": "T Nguyen-Dumont",
      "doi-asserted-by": "crossref",
      "first-page": "48",
      "journal-title": "BMC Med Genomics",
      "key": "9851_CR47",
      "unstructured": "Nguyen-Dumont T, Teo ZL, Pope BJ, Hammet F, Mahmoodi M, Tsimiklis H, Sabbaghian N, Tischkowitz M, Foulkes WD, Giles GG, Hopper JL, Southey MC, Park DJ (2013) Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2. BMC Med Genomics 6:48",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2014.57.1414",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "304",
      "journal-title": "J Clin Oncol",
      "key": "9851_CR48",
      "unstructured": "Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L, Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C, Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304–311",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1002/pbc.25201",
      "author": "MA Smith",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "journal-title": "Pediatr Blood Cancer",
      "key": "9851_CR49",
      "unstructured": "Smith MA, Hampton OA, Reynolds CP, Kang MH, Maris JM, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Wu J, Kurmasheva RT, Wheeler DA, Houghton PJ (2015) Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673. Pediatr Blood Cancer 62:91–98",
      "volume": "62",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-10-0893",
      "author": "MC Villarroel",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "journal-title": "Mol Cancer Ther",
      "key": "9851_CR50",
      "unstructured": "Villarroel MC, Rajeshkumar NV, Garrido-Laguna I, De Jesus-Acosta A, Jones S, Maitra A, Hruban RH, Eshleman JR, Klein A, Laheru D, Donehower R, Hidalgo M (2011) Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther 10:3–8",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60892-6",
      "author": "A Tutt",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "journal-title": "Lancet",
      "key": "9851_CR51",
      "unstructured": "Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376:235–244",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1038/bjc.2013.295",
      "author": "ZL Teo",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "journal-title": "Br J Cancer",
      "key": "9851_CR52",
      "unstructured": "Teo ZL, Provenzano E, Dite GS, Park DJ, Apicella C, Sawyer SD, James PA, Mitchell G, Trainer AH, Lindeman GJ, Shackleton K, Cicciarelli L, Buys SS, Andrulis IL, Mulligan AM, Glendon G, John EM, Terry MB, Daly M, Odefrey FA, Nguyen-Dumont T, Giles GG, Dowty JG, Winship I, Goldgar DE, Hopper JL, Southey MC (2013) Tumour morphology predicts PALB2 germline mutation status. Br J Cancer 109:154–163",
      "volume": "109",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0140-6736(96)10109-4",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "1505",
      "journal-title": "Lancet",
      "key": "9851_CR53",
      "unstructured": "Breast Cancer Linkage Consortium, Lakhani SR, Easton D, Stratton MR (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505–1510",
      "volume": "349",
      "year": "1997"
    },
    {
      "DOI": "10.1046/j.1365-2559.2000.00880.x",
      "author": "S Shousha",
      "doi-asserted-by": "crossref",
      "first-page": "182",
      "journal-title": "Histopathology",
      "key": "9851_CR54",
      "unstructured": "Shousha S (2000) Medullary carcinoma of the breast and BRCA1 mutation. Histopathology 37:182–185",
      "volume": "37",
      "year": "2000"
    },
    {
      "author": "F Eisinger",
      "first-page": "1588",
      "journal-title": "Cancer Res",
      "key": "9851_CR55",
      "unstructured": "Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de Paillerets B, Peyrat JP, Longy M, Guinebretiere JM, Sauvan R, Noguchi T, Birnbaum D, Sobol H (1998) Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 58:1588–1592",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s10549-008-9945-0",
      "author": "MJ Garcia",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9851_CR56",
      "unstructured": "Garcia MJ, Fernandez V, Osorio A, Barroso A, Llort G, Lazaro C, Blanco I, Caldes T, de la HM, Ramon YC, Alonso C, Tejada MI, San Roman C, Robles-Diaz L, Urioste M, Benitez J (2009) Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res Treat 113:545–551",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1046/j.1524-4741.2003.09326.x",
      "author": "C Kroupis",
      "doi-asserted-by": "crossref",
      "first-page": "260",
      "journal-title": "Breast J",
      "key": "9851_CR57",
      "unstructured": "Kroupis C, Lianidou E, Goutas N, Ladopoulou A, Konstantopoulou I, Pantazidis A, Yannoukakos D, Efstathiou E, Vourlidis N, Tsionou C (2003) Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutation. Breast J 9:260–262",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1371/journal.pone.0047993",
      "author": "F Pern",
      "doi-asserted-by": "crossref",
      "first-page": "e47993",
      "journal-title": "PLoS One",
      "key": "9851_CR58",
      "unstructured": "Pern F, Bogdanova N, Schurmann P, Lin M, Ay A, Langer F, Hillemanns P, Christiansen H, Park-Simon TW, Dork T (2012) Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer. PLoS One 7:e47993",
      "volume": "7",
      "year": "2012"
    }
  ],
  "reference-count": 58,
  "references-count": 58,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9851-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}